Jan Basile to Diabetic Angiopathies
This is a "connection" page, showing publications Jan Basile has written about Diabetic Angiopathies.
Connection Strength
0.445
-
The potential of sodium glucose cotransporter 2 (SGLT2) inhibitors to reduce cardiovascular risk in patients with type 2 diabetes (T2DM). J Diabetes Complications. 2013 May-Jun; 27(3):280-6.
Score: 0.382
-
Rationale and design for the blood pressure intervention of the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial. Am J Cardiol. 2007 Jun 18; 99(12A):44i-55i.
Score: 0.064